Impaired Antibody Response to Pneumococcal Vaccine after Treatment for Hodgkin's Disease

scientific article published on August 31, 1978

Impaired Antibody Response to Pneumococcal Vaccine after Treatment for Hodgkin's Disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1056/NEJM197808312990903
P8608Fatcat IDrelease_wrjunclxkrbqdixbxjyyt3unam
P953full work available at URLhttp://www.nejm.org/doi/pdf/10.1056/NEJM197808312990903
P698PubMed publication ID28483

P2093author name stringAisenberg AC
Siber GR
Schiffman G
Weinstein HJ
Weitzman SA
P2860cites workThe New England Journal of MedicineQ582728
Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's diseaseQ35904611
Relation Between Splenectomy and Subsequent Infection: A Clinical StudyQ36050498
Acute Bacteremia in Asplenic Renal Transplant PatientsQ39145537
Vaccination and Revaccination with Polyvalent Pneumococcal Polysaccharide Vaccines in Adults and InfantsQ39180306
Immune response after splenectomyQ39472066
Acute nonlymphocytic leukemia.A delayed complication of Hodgkin's disease therapy: Analysis of 109 casesQ39865835
Impaired Humoral Immunity in Treated Hodgkin's DiseaseQ40650233
Immunogenicity in Weanling Rabbits of a Polyribophosphate Complex from Haemophilus influenzae Type bQ40654329
Bacterial infections in pediatric Hodgkin's disease.Relationship to radiotherapy, chemotherapy and splenectomyQ40676103
Studies of immunologic reactions of patients with Hodgkin's disease; antibody reaction to typhoid immunizationQ41062237
Fulminant sepsis after the successful treatment of Hodgkin's diseaseQ41226733
Influenza immunization in immunosuppressed childrenQ43898292
The syndrome of asplenia, pneumococcal sepsis, and disseminated intravascular coagulationQ44146275
Septicemia and meningitis in children splenectomized for hodgkin's diseaseQ44685693
Federation ProceedingsQ45106928
NORMAL RESPONSE OF SICKLE CELL ANEMIA PATIENTS TO IMMUNIZATION WITH SALMONELLA VACCINES.Q46165494
Influenza immunization of adult patients with malignant diseasesQ50948355
Hematologic neoplasia in patients treated for Hodgkin's diseaseQ67700700
Staging laparotomy and splenectomy: treatment and complications of Hodgkin's disease in childrenQ68227430
Serious infection after splenectomy for the staging of Hodgkin's diseaseQ68766950
Immunogenicity of the Group A and Group C Meningococcal Polysaccharides in ChildrenQ69373288
Hazard of Overwhelming Infection after Splenectomy in ChildhoodQ72218645
Antibody formation in Hodgkin's diseaseQ76430485
Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodiesQ93734553
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectantibodyQ79460
vaccineQ134808
pneumococcal vaccineQ14538008
P304page(s)442-448
P577publication date1978-08-01
1978-08-31
P1433published inThe New England Journal of MedicineQ582728
P1476titleImpaired Antibody Response to Pneumococcal Vaccine after Treatment for Hodgkin's Disease
P478volume299

Reverse relations

cites work (P2860)
Q343900722013 IDSA clinical practice guideline for vaccination of the immunocompromised host
Q72608163A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques
Q40895935Active immunization of children with leukemia and other malignancies
Q67004314An in Vivo Model for Assessing Effects of Drugs and Toxicants on Immunocompetence
Q39760912Antibacterial therapy in patients with malignancies
Q35231638Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines
Q73414332Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia
Q77120743Approach to fever in the neutropenic host
Q28294678Cells in the marginal zone of the spleen
Q34101106Comparative Immunogenicity of Group 6 Pneumococcal Type 6A(6) and Type 6B(26) Capsular Polysaccharides
Q36958120Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate
Q40774499Critical appraisal of immunization strategies for prevention of infection in the compromised host.
Q36437096Cross-immunogenicity of pneumococcal group 9 capsular polysaccharides in adult volunteers.
Q43888942Development of anti-polysaccharide antibodies in asplenic children
Q45803206Effect of antineoplastic drugs on human leukocyte-mediated cytotoxicity against herpes simplex virus infected cells
Q36454624Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay
Q37110954Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates
Q40286177Gram-positive pneumonias.
Q33903305Graphical method for evaluating antibody response to vaccines
Q24655614Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen
Q39888192Hodgkin's disease. Results in diagnosis and treatment (author's transl)
Q34407550Hyposplenism in gastrointestinal disease
Q40598660Immunization for children treated for solid tumors: what are the guidelines?
Q36341232Immunodeterminant specificity of human immunity to type III group B streptococcus
Q71010729Immunogenicity of Haemophilus influenzae type b polysaccharide--diphtheria toxoid conjugate vaccine in adults
Q66706286Impaired Response to Pneumococcal Vaccine in Hodgkin's Disease
Q71085322Impaired antibody responses to a pneumococcal polysaccharide vaccine in patients with non-Hodgkin's lymphoma in remission
Q69861077Impaired human antibody response to the thymus-independent antigen, DNP-Ficoll, after splenectomy. Implications for post-splenectomy infections
Q40300808Infectious complications in the child with cancer. I. Pathophysiology of the compromised host and the initial evaluation and management of the febrile cancer patient
Q72610389Influence of Preimmunization Antibody Levels on the Specificity of the Immune Response to Related Polysaccharide Antigens
Q28079486Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and Safety
Q34526987Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A
Q44185029Late infections following splenectomy in Hodgkin's disease
Q40174128Limitations of current antimicrobial therapy in the immunosuppressed host: Looking at both sides of the coin
Q70969996Longitudinal studies of blood lymphocyte capacity in Hodgkin's disease
Q44867862Management of stages I to III Hodgkin disease in children
Q34272151Methods for the analysis of antibody responses to vaccines or other immune stimuli
Q39190339Non-Hodgkin's lymphoma presenting as 'chronic active toxoplasmosis'.
Q41143965Optimal delivery of vaccines: clinical pharmacokinetic considerations.
Q35806682Overwhelming pneumococcal infection in a hyposplenic adult
Q39261416Pneumococcal Disease and its Prevention with Polyvalent Pneumococcal Polysaccharide Vaccines-A Review
Q44751520Pneumococcal antibody levels in patients with acute lung infiltrates
Q70672365Pneumococcal bacteremia in patients with neoplastic diseases
Q45014870Pneumococcal infections among immunised and splenectomised patients in Israel
Q36974445Pneumococcal polysaccharide vaccines: Indications, efficacy and recommendations
Q39772963Pneumococcal sepsis and meningitis in vaccinated subjects: a review of 55 reported cases
Q72647759Pneumococcal vaccination in patients with chronic renal disease and renal allograft recipients
Q70618936Pneumococcal vaccination: the response of patients with alcoholic liver cirrhosis
Q40301722Postsplenectomy infection.
Q47273484Power and sample size calculations for studies involving linear regression
Q34260060Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis
Q41476113Preservation of splenic function in adults and children with injured spleens
Q54425326Prophylactic effect of human immunoglobulin against pneumococcal post-splenectomy sepsis in the rat.
Q37013271Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumococci
Q73253046Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma
Q72147572Response of renal allograft recipients to pneumococcal vaccine
Q71098285Response to Pneumococcal Vaccine in the Elderly: No Enhancement by Indomethacin
Q43593209Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin's disease. Children's Cancer Study Group Report
Q36985836Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid
Q37027154Spectrum of immunodeficiencies with Hodgkin's disease
Q39665560Splenic function: physiology and splenic hypofunction
Q39812056Staging in Hodgkin's disease
Q40149015Staging laparotomy with splenectomy in children and adolescents with Hodgkin's disease
Q39241566The Immune Response of Vaccination Against Hepatitis B virus in Iranian Patients Undergoing Chemotherapy
Q50190430The Risk of Sepsis in the Asplenic Adult
Q39778342The Staging and Treatment of Hodgkin's Disease
Q39702859The changing face of Hodgkin's disease
Q39899038The immunopathology of Hodgkin's disease
Q40736481The incidence of post-splenectomy sepsis and herpes zoster in children and adolescents with Hodgkin disease
Q70150864The overwhelming postsplenectomy sepsis problem
Q41610899Therapy-Induced Alterations in Host Defense in Children Receiving Therapy for Cancer

Search more.